Inhibitor Therapeutics Inc banner

Inhibitor Therapeutics Inc
OTC:INTI

Watchlist Manager
Inhibitor Therapeutics Inc Logo
Inhibitor Therapeutics Inc
OTC:INTI
Watchlist
Price: 0.09 USD -17.43% Market Closed
Market Cap: $15.5m

Wall Street
Price Targets

INTI Price Targets Summary
Inhibitor Therapeutics Inc

There are no price targets for INTI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Inhibitor Therapeutics Inc Competitors:
Price Targets
ESQ
Esquire Financial Holdings Inc
14% Upside
RYI
Ryerson Holding Corp
43% Upside
AMAL
Amalgamated Bank
9% Upside
RLMD
Relmada Therapeutics Inc
109% Upside
0HQ1
Brooks Automation Inc
79% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Revenue forecast
is not available for
Inhibitor Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Inhibitor Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Net Income forecast
is not available for
Inhibitor Therapeutics Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INTI's stock price target?
Not Available

INTI doesn't have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett